2019年コロナウイルス病 (COVID-19) パンデミックが尿道性悪性腫瘍の進行に及ぼす影響:比較研究

Alper Keskin¹, Enis Mert Yorulmaz², Kursad Donmez³

¹Department of Urology, Denizli State Hospital, Denizli, Türkiye.

Frontiers in urology

|August 22, 2025

まとめ

COVID-19 パンデミック中の治療の遅れは,前立腺がんと腎臓がんの病理的段階を悪化させた. 膀と丸の癌は影響を受けず,回復力のあるがん治療の必要性を強調した.

科学分野:

泌尿器科
腫瘍学
公衆衛生

背景:

COVID-19 パンデミックは,世界的に医療サービスに重大な障害をもたらしました.
これらの障害は様々ながんの早期診断と治療に影響を与え,病気の進行につながる可能性があります.

研究の目的:

COVID-19 パンデミック中の治療の遅延が泌尿器の悪性腫瘍の病理的段階の進行と関連しているかどうかを調査する.
前立腺癌,膀癌,腎臓癌, testicular がんにおけるパンデミック前とパンデミック後の手術結果を比較する.

主な方法:

泌尿器官がんの急性手術を受けた368人の患者を比較した.
患者は,流行前 (PREP) と流行後 (POSTP) のコホート (2019年4月~2022年3月) に分けられました.
適切な統計検査 (p<0. 05) を用いて臨床的,実験的,病理学的データを分析した.

主要な成果:

POSTP前立腺切除の患者は,より高いPSA,より大きな腫瘍の関与,および増加した前立腺外伸縮を示しました.
パンデミック時代の腎臓腫瘍はより大きなもので手術前ヘモグロビンが低かったので病気が進行したことを示しています
コホート間の膀または testicular がんの有意な病理的段階の違いは見つかりませんでした.

結論:

COVID-19に関連するケア障害は,前立腺がんや腎臓がんにおける有害な病理的特徴と関連していた.
膀および testicular がんは,パンデミックに関連した遅延のために重要な段階の移行を示さなかった.
発見は,健康危機の進行を緩和するために堅固ながん治療の必要性を強調しています.

キーワード:

コロナウイルスパンデミック遅延病理的段階腫瘍の進行泌尿器科がん

さらに関連する動画

07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K

07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

400

関連する概念動画

02:07

Tumor Progression

6.5K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

6.5K

03:03

mTOR Signaling and Cancer Progression

3.9K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

3.9K

01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...

01:27

Tumor Immunotherapy

660

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

660

01:21

Cancer Survival Analysis

453

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

453

02:17

The Tumor Microenvironment

6.8K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...